GENELUX CORPORATION Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GENELUX CORPORATION stock issued during period, value, new issues for the quarter ending 2026-06-30 was $339.00K.
- GENELUX CORPORATION stock issued during period, value, new issues for the quarter ending 2026-03-31 was $18.52M, a 93.92% increase year-over-year.
- GENELUX CORPORATION stock issued during period, value, new issues for the quarter ending 2025-03-31 was $9.55M.
- GENELUX CORPORATION stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- GENELUX CORPORATION stock issued during period, value, new issues for fiscal 2023 was $25.14M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $339.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $18.52M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $9.55M 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $25.14M 10-K · filed 2025-03-28 |
| 2023-09-30 | $3.50M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $21.64M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $12.63M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |